UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011092
Receipt number R000012909
Scientific Title A clinical study of the efficacy of 5HT3 receptor antagonist (palonocetron) in malignant lymphoma patients treated with (R-)CHOP regimen
Date of disclosure of the study information 2013/08/01
Last modified on 2019/12/11 17:32:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study of the efficacy of 5HT3 receptor antagonist (palonocetron) in malignant lymphoma patients treated with (R-)CHOP regimen

Acronym

A clinical study of the efficacy of palonocetron in patients treated with (R-)CHOP regimen

Scientific Title

A clinical study of the efficacy of 5HT3 receptor antagonist (palonocetron) in malignant lymphoma patients treated with (R-)CHOP regimen

Scientific Title:Acronym

A clinical study of the efficacy of palonocetron in patients treated with (R-)CHOP regimen

Region

Japan


Condition

Condition

Malignant Lymphoma

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

we intent to evaluate the efficacy of palonocetron to prevent nausea and vomiting in patients treated with (R-)CHOP regimen

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of nausea, vomiting, and anorexia

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

we use palonosetron as anti-emesis drug, and ask patients to fill out an emesis diary

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)The patients who are historically confirmed as Non-Hodgikin Lymphoma, and planed to treat with (R-)CHOP regimen
2)The patients who don't have nausea or vomiting
3)The patients who have not been treated with chemotherapy
4)The patients who are expected to survive more than 3 months
5)The patients whose ECOG performance status are 0 to 2
6)The patients who are able to fill out an emesis diary
7)The patients who are more than 18 years old, and agree to participate in this study with document

Key exclusion criteria

1)The patients who will have nausea and vomiting except for chemotherapy
2)The patients who have contraindication to use palonocetron
3)The patients who need to reduce CHOP regimen
4)The patients who need to reduce or stop to use prednisolone
5)The patients who are HIV antibody positive, HBs antigen positive, or HCV antibody positive
6)The patients whose doctor judge as ineligible

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hironobu Minami

Organization

Department of Medicine, Kobe University Graduate School of Medicine

Division name

Division of Medical Oncology/Hematology

Zip code


Address

7-5-1, Kusunoki-Cho, Chuo-ku, Kobe city, Hyogo prefecture, Japan

TEL

078-382-5820

Email

yhmiyata@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiharu Miyata

Organization

Department of Medicine, Kobe University Graduate School of Medicine

Division name

Division of Medical Oncology/Hematology

Zip code


Address

7-5-1, Kusunoki-Cho, Chuo-ku, Kobe city, Hyogo prefecture, Japan

TEL

078-382-5820

Homepage URL


Email

yhmiyata@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

Institute

Department

Personal name



Funding Source

Organization

Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007%2Fs12185-016-2089-9

Number of participants that the trial has enrolled

50

Results

The primary endpoint was the overall occurrence rate of nausea, vomiting, and anorexia; these rates were 56%, 12%, and 62%, respectively, including all grades.

Results date posted

2019 Year 12 Month 11 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 17 Day

Date of IRB

2013 Year 07 Month 24 Day

Anticipated trial start date

2013 Year 08 Month 01 Day

Last follow-up date

2015 Year 05 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 07 Month 02 Day

Last modified on

2019 Year 12 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012909


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name